This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Clinical improvement of ≥4 points on the NIH Stroke Scale (NIHSS) was seen in 47% of patients 24 hours after treatment with IV tissue plasminogen activator (tPA) for acute ischemic stroke.1 Arterial recanalization can be associated with early recovery;2 following improvement, however, 15% of patients experience clinical deterioration.3 Transcranial Doppler (TCD) ultrasonography has been used to detect arterial occlusion and monitor recanalization during thrombolysis.4 The authors report the clinical and TCD findings in a patient who improved, then subsequently deteriorated, while receiving tPA therapy.
Case report.
A 42-year-old, right-handed woman was seen 80 minutes after the acute onset of right hemiplegia, global aphasia, eye deviation to the left, and a right homonymous hemianopsia (NIHSS score 24). Her medial history included smoking, non–insulin-dependent diabetes mellitus, and peripheral vascular disease requiring bilateral femoral–popliteal bypasses. She had no history of cardiac or cerebral ischemia, and was not taking any antiplatelet treatment. A head CT scan showed a hyperdense left middle cerebral artery (MCA) and no hemorrhage.
At 90 minutes from symptom onset, a TCD was performed according to a published protocol,4 using a single-channel, 2-MHz portable unit (Multigon 500M, Yonkers, NY), and head-frame fixation (Marc 500, Spencer Technologies, Seattle, WA).
The TCD was consistent with a proximal M1 MCA and A1 anterior cerebral artery (ACA) occlusion ( figure, frame 1) followed by rapid progression to a terminal internal carotid artery (ICA) occlusion (see the figure, frame 2). Within 5 minutes, the …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
